The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Aesthetic Injectables-Global Market Insights and Sales Trends 2024
Synopsis
Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance
The global Aesthetic Injectables market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Aesthetic Injectables in various end use industries. The expanding demands from the Hospital and Beauty Clinic, are propelling Aesthetic Injectables market. Sunken Cheeks or Temples, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines) segment is estimated at % CAGR for the next seven-year period.
The total size of the global beauty industry in 2022 was about US$ 427 billion, with the sales of skin care products was about US$ 190 billion, perfumes US$ 70 billion, color cosmetics US$ 80 billion, hair care products US$ 90 billion. Head beauty and personal care companies are concentrated in Europe and the United States. More than one-third of the top 100 companies are headquartered in the United States, and 22.9% of the companies are located in France.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aesthetic Injectables, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Aesthetic Injectables market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Aesthetic Injectables market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aesthetic Injectables sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Aesthetic Injectables covered in this report include Allergan Plc, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Plc, Teoxane SA, Bohus BioTech AB, AbbVie Inc and Huadong Medicine Co., Ltd, etc.
The global Aesthetic Injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan Plc
Galderma SA
Merz Pharma GmbH & Co KgaA
Sinclair Pharma Plc
Teoxane SA
Bohus BioTech AB
AbbVie Inc
Huadong Medicine Co., Ltd
Global Aesthetic Injectables market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aesthetic Injectables market, Segment by Type:
Sunken Cheeks or Temples
Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
Plumping Up Lips
Enhancing Facial Contour
Global Aesthetic Injectables market, by Application
Hospital
Beauty Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Aesthetic Injectables manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Aesthetic Injectables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance
The global Aesthetic Injectables market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Aesthetic Injectables in various end use industries. The expanding demands from the Hospital and Beauty Clinic, are propelling Aesthetic Injectables market. Sunken Cheeks or Temples, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines) segment is estimated at % CAGR for the next seven-year period.
The total size of the global beauty industry in 2022 was about US$ 427 billion, with the sales of skin care products was about US$ 190 billion, perfumes US$ 70 billion, color cosmetics US$ 80 billion, hair care products US$ 90 billion. Head beauty and personal care companies are concentrated in Europe and the United States. More than one-third of the top 100 companies are headquartered in the United States, and 22.9% of the companies are located in France.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aesthetic Injectables, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Aesthetic Injectables market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Aesthetic Injectables market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aesthetic Injectables sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Aesthetic Injectables covered in this report include Allergan Plc, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Plc, Teoxane SA, Bohus BioTech AB, AbbVie Inc and Huadong Medicine Co., Ltd, etc.
The global Aesthetic Injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan Plc
Galderma SA
Merz Pharma GmbH & Co KgaA
Sinclair Pharma Plc
Teoxane SA
Bohus BioTech AB
AbbVie Inc
Huadong Medicine Co., Ltd
Global Aesthetic Injectables market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aesthetic Injectables market, Segment by Type:
Sunken Cheeks or Temples
Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
Plumping Up Lips
Enhancing Facial Contour
Global Aesthetic Injectables market, by Application
Hospital
Beauty Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Aesthetic Injectables manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Aesthetic Injectables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Aesthetic Injectables Market Overview
1.1 Aesthetic Injectables Product Overview
1.2 Aesthetic Injectables Market Segment by Type
1.2.1 Sunken Cheeks or Temples
1.2.2 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
1.2.3 Plumping Up Lips
1.2.4 Enhancing Facial Contour
1.3 Global Aesthetic Injectables Market Size by Type
1.3.1 Global Aesthetic Injectables Market Size Overview by Type (2018-2029)
1.3.2 Global Aesthetic Injectables Historic Market Size Review by Type (2018-2023)
1.3.3 Global Aesthetic Injectables Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aesthetic Injectables Sales Breakdown by Type (2018-2023)
1.4.2 Europe Aesthetic Injectables Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Aesthetic Injectables Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Aesthetic Injectables Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Aesthetic Injectables Sales Breakdown by Type (2018-2023)
2 Global Aesthetic Injectables Market Competition by Company
2.1 Global Top Players by Aesthetic Injectables Sales (2018-2023)
2.2 Global Top Players by Aesthetic Injectables Revenue (2018-2023)
2.3 Global Top Players by Aesthetic Injectables Price (2018-2023)
2.4 Global Top Manufacturers Aesthetic Injectables Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aesthetic Injectables Market Competitive Situation and Trends
2.5.1 Aesthetic Injectables Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Aesthetic Injectables Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aesthetic Injectables as of 2022)
2.7 Date of Key Manufacturers Enter into Aesthetic Injectables Market
2.8 Key Manufacturers Aesthetic Injectables Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aesthetic Injectables Status and Outlook by Region
3.1 Global Aesthetic Injectables Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aesthetic Injectables Historic Market Size by Region
3.2.1 Global Aesthetic Injectables Sales in Volume by Region (2018-2023)
3.2.2 Global Aesthetic Injectables Sales in Value by Region (2018-2023)
3.2.3 Global Aesthetic Injectables Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Aesthetic Injectables Forecasted Market Size by Region
3.3.1 Global Aesthetic Injectables Sales in Volume by Region (2024-2029)
3.3.2 Global Aesthetic Injectables Sales in Value by Region (2024-2029)
3.3.3 Global Aesthetic Injectables Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aesthetic Injectables by Application
4.1 Aesthetic Injectables Market Segment by Application
4.1.1 Hospital
4.1.2 Beauty Clinic
4.2 Global Aesthetic Injectables Market Size by Application
4.2.1 Global Aesthetic Injectables Market Size Overview by Application (2018-2029)
4.2.2 Global Aesthetic Injectables Historic Market Size Review by Application (2018-2023)
4.2.3 Global Aesthetic Injectables Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aesthetic Injectables Sales Breakdown by Application (2018-2023)
4.3.2 Europe Aesthetic Injectables Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Aesthetic Injectables Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Aesthetic Injectables Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Aesthetic Injectables Sales Breakdown by Application (2018-2023)
5 North America Aesthetic Injectables by Country
5.1 North America Aesthetic Injectables Historic Market Size by Country
5.1.1 North America Aesthetic Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aesthetic Injectables Sales in Volume by Country (2018-2023)
5.1.3 North America Aesthetic Injectables Sales in Value by Country (2018-2023)
5.2 North America Aesthetic Injectables Forecasted Market Size by Country
5.2.1 North America Aesthetic Injectables Sales in Volume by Country (2024-2029)
5.2.2 North America Aesthetic Injectables Sales in Value by Country (2024-2029)
6 Europe Aesthetic Injectables by Country
6.1 Europe Aesthetic Injectables Historic Market Size by Country
6.1.1 Europe Aesthetic Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aesthetic Injectables Sales in Volume by Country (2018-2023)
6.1.3 Europe Aesthetic Injectables Sales in Value by Country (2018-2023)
6.2 Europe Aesthetic Injectables Forecasted Market Size by Country
6.2.1 Europe Aesthetic Injectables Sales in Volume by Country (2024-2029)
6.2.2 Europe Aesthetic Injectables Sales in Value by Country (2024-2029)
7 Asia-Pacific Aesthetic Injectables by Region
7.1 Asia-Pacific Aesthetic Injectables Historic Market Size by Region
7.1.1 Asia-Pacific Aesthetic Injectables Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aesthetic Injectables Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Aesthetic Injectables Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aesthetic Injectables Forecasted Market Size by Region
7.2.1 Asia-Pacific Aesthetic Injectables Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aesthetic Injectables Sales in Value by Region (2024-2029)
8 Latin America Aesthetic Injectables by Country
8.1 Latin America Aesthetic Injectables Historic Market Size by Country
8.1.1 Latin America Aesthetic Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aesthetic Injectables Sales in Volume by Country (2018-2023)
8.1.3 Latin America Aesthetic Injectables Sales in Value by Country (2018-2023)
8.2 Latin America Aesthetic Injectables Forecasted Market Size by Country
8.2.1 Latin America Aesthetic Injectables Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aesthetic Injectables Sales in Value by Country (2024-2029)
9 Middle East and Africa Aesthetic Injectables by Country
9.1 Middle East and Africa Aesthetic Injectables Historic Market Size by Country
9.1.1 Middle East and Africa Aesthetic Injectables Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aesthetic Injectables Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Aesthetic Injectables Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aesthetic Injectables Forecasted Market Size by Country
9.2.1 Middle East and Africa Aesthetic Injectables Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aesthetic Injectables Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan Plc
10.1.1 Allergan Plc Company Information
10.1.2 Allergan Plc Introduction and Business Overview
10.1.3 Allergan Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Plc Aesthetic Injectables Products Offered
10.1.5 Allergan Plc Recent Development
10.2 Galderma SA
10.2.1 Galderma SA Company Information
10.2.2 Galderma SA Introduction and Business Overview
10.2.3 Galderma SA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Galderma SA Aesthetic Injectables Products Offered
10.2.5 Galderma SA Recent Development
10.3 Merz Pharma GmbH & Co KgaA
10.3.1 Merz Pharma GmbH & Co KgaA Company Information
10.3.2 Merz Pharma GmbH & Co KgaA Introduction and Business Overview
10.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Products Offered
10.3.5 Merz Pharma GmbH & Co KgaA Recent Development
10.4 Sinclair Pharma Plc
10.4.1 Sinclair Pharma Plc Company Information
10.4.2 Sinclair Pharma Plc Introduction and Business Overview
10.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sinclair Pharma Plc Aesthetic Injectables Products Offered
10.4.5 Sinclair Pharma Plc Recent Development
10.5 Teoxane SA
10.5.1 Teoxane SA Company Information
10.5.2 Teoxane SA Introduction and Business Overview
10.5.3 Teoxane SA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teoxane SA Aesthetic Injectables Products Offered
10.5.5 Teoxane SA Recent Development
10.6 Bohus BioTech AB
10.6.1 Bohus BioTech AB Company Information
10.6.2 Bohus BioTech AB Introduction and Business Overview
10.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bohus BioTech AB Aesthetic Injectables Products Offered
10.6.5 Bohus BioTech AB Recent Development
10.7 AbbVie Inc
10.7.1 AbbVie Inc Company Information
10.7.2 AbbVie Inc Introduction and Business Overview
10.7.3 AbbVie Inc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.7.4 AbbVie Inc Aesthetic Injectables Products Offered
10.7.5 AbbVie Inc Recent Development
10.8 Huadong Medicine Co., Ltd
10.8.1 Huadong Medicine Co., Ltd Company Information
10.8.2 Huadong Medicine Co., Ltd Introduction and Business Overview
10.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Products Offered
10.8.5 Huadong Medicine Co., Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aesthetic Injectables Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aesthetic Injectables Industrial Chain Analysis
11.4 Aesthetic Injectables Market Dynamics
11.4.1 Aesthetic Injectables Industry Trends
11.4.2 Aesthetic Injectables Market Drivers
11.4.3 Aesthetic Injectables Market Challenges
11.4.4 Aesthetic Injectables Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aesthetic Injectables Distributors
12.3 Aesthetic Injectables Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
